Life Science Leader Magazine Supplements

CRO Leadership Awards 2017

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/818304

Contents of this Issue

Navigation

Page 35 of 45

CAPABILITIES COMPATIBILITY EXPERTISE QUALITY RELIABILITY K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M Company Profiles 2017 CRO LEADERSHIP AWARDS WINNERS 34 THE CRO LEADERSHIP AWARDS 2017 LIFESCIENCELEADER.COM SERVICES & CAPABILITIES: Covance Marketplace (partnering network), early phase dev. solutions (Preclinical to FIH/POC), genomics, companion diag- nostics, biomarkers, informatics, market access svcs, mobile health, patient access & provider services, regulatory, risk-based monitoring, sample mgmt. THERAPEUTIC AREAS: asthma, allergy, autoim- mune, inflamm., cardiovascular, CNS, dermatology, gastroenterology, gen. medicine, hematology, infect. disease, metabolic, endocrine, musculoskeletal, nephrology, nutrition, oncology/immuno-oncology, ophthalmology, pulmonary/respiratory, rep. health, rheumatology, urology DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Pre-Clinical, Clinical, Phase 1, Phase 2, Phase 3 Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics MAIN SERVICE AREAS: Lab, Pre-Clinical, Full Service Clinical "At Covance, we are united by our strong sense of purpose at this time of extraordinary advances in healthcare. We bring clients a unique perspec- tive, combining our breadth of capabilities from research to real world, with deep scientific exper- tise. We are enabled by award-winning technol- ogy and informed by leading data and analytics. Above all, we are driven to improve health and improve lives, inspiring us to deliver more for clients. We truly appreciate this recognition." JOHN RATLIFF CEO CATEGORIES WON: Covance Inc. Princeton, New Jersey www.covance.com Phone: 609-452-4440 Contact: Sue Maynard Email: susan.maynard@covance.com Key locations: Princeton, NJ; Indianapolis, IN; Madison, WI; Leeds, UK; Shanghai; Singapore INDIVIDUAL ATTRIBUTE AWARDS: data quality, operational excellence, technology for real-time access to data SERVICES & CAPABILITIES: full-service Phase 1-2a trials, including medical writing & data mgmt.; Phase 2b-4 clinical trials & site network; de- identified patient datasets, including EHRs, claims, Rx & lab data THERAPEUTIC AREAS: nephrology, diabetes, cardiovascular disease, pulmonology, oncol- ogy, autoimmune disorders, renal impairment, hepatic impairment, healthy normal volunteers, first-in-human, dose-ranging, ADME, internal medicine DRUG LIFE CYCLE STAGES: Research & Development: Clinical, Phase 1, Phase 2, Phase 3 MAIN SERVICE AREAS: Full Service Clinical "As a wholly owned subsidiary of a multi-specialty healthcare provider, DCR is unique in the exper- tise and insights we can offer our clients. Our large network of clinical sites, broad therapeutic reach, and de-identified patient datasets enable us to provide data-driven feasibility and rapid site start-up. We have capabilities across the spectrum of drug development, including two hospital-based clinical pharmacology units, and I'm delighted our clients are seeing the value we can provide them." AMY YOUN VP & General Manager CATEGORIES WON: DaVita Clinical Research Minneapolis, Minnesota www.davitaclinicalresearch.com Phone: 612-852-7000 Contact: Kevin Goudreau Email: kevin.goudreau@davita.com Key locations: Minneapolis, MN; Denver, CO; Los Angeles, CA; Las Vegas, NV; Houston, TX; New York, NY; Colorado Springs, CA; Dusseldorf, Germany INDIVIDUAL ATTRIBUTE AWARDS: data quality, meeting overall project timelines, offered innovative solutions, operational excellence, responsiveness, tech- nology for real-time access to data SERVICES & CAPABILITIES: The DCRI conducts multinational clinical trials, manages patient registries, and performs outcomes research. DCRI research spans disciplines from pediatrics to geri- atrics, primary care to subspecialty medicine, and genomics to proteomics. THERAPEUTIC AREAS: cardiovascular, respiratory, neuroscience, infectious diseases, gastroenterology, hepatology, musculoskeletal, pediatrics DRUG LIFE CYCLE STAGES: Research & Development: Clinical, Phase 1, Phase 2, Phase 3 MAIN SERVICE AREAS: Full Service Clinical "It's an honor to be recognized again for the work we are doing to make tomorrow better than today for patients around the world. This award is evi- dence that our peers understand the value of the unique perspective the DCRI brings to the most vital healthcare questions of the day." ERIC PETERSON Executive Director CATEGORIES WON: Duke Clinical Research Institute Durham, North Carolina www.dcri.org Phone: 919-668-8700 Contact: Matt Gross Email: matt.gross@duke.edu Key locations: Durham, North Carolina INDIVIDUAL ATTRIBUTE AWARDS: data quality, meeting overall project timelines, offered innovative solutions, operational excellence, responsiveness, tech- nology for real-time access to data

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2017